SCHEMBL18507331

SCHEMBL18507331

CCn1ncc(Cc2cc([C@@H](C)CCc3ncc(C(C)C)o3)cc(F)n2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18507169 0.70 LOXL2 (0.30) —
SCHEMBL20079517 0.67 NPC1 (0.32) —
SCHEMBL12394807 0.61 SORT1 (0.42) —
SCHEMBL13534126 0.59 CCNB2 (0.38) —
SCHEMBL10274589 0.57 — —
SCHEMBL13481297 0.57 CCNB2 (0.36) —
SCHEMBL19132977 0.57 CCNB2 (0.32) —
SCHEMBL12746787 0.56 CCNB2 (0.39) —
Bromide SCHEMBL6855980 0.56 CHRM2 (0.38) —
SCHEMBL12417808 0.56 CCNB2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10004732-B2 Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors NOVARTIS AG (CH) 2018-06-26 — — US disclosed
US-20170042889-A1 AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2017-02-16 — — US disclosed
Send feedback